RPS4XP11: A Potential Drug Target and Biomarker (G441550)

Target Name: RPS4XP11

NCBI ID: G441550

RPS4XP11

Other Name(s): RPS4P11 | Ribosomal protein S4X pseudogene 11 | ribosomal protein S4X pseudogene 11 | RPS4X_2_1029

RPS4XP11: A Potential Drug Target and Biomarker

RPS4XP11 is a gene that encodes a protein known as RPS4XP11. RPS4XP11 is a member of the RPS4 gene family, which is known for its role in regulating protein stability and localization in the endoplasmic reticulum (ER) and cytosol. implicated in a wide range of cellular processes, including protein quality control, stress response, and autophagy.

The search for potential drug targets and biomarkers is an important aspect of modern medicine. Drug development involves identifying small molecules or other compounds that can interact with specific targets and cause a desired response in the cell. These targets can be identified through various means, including high-throughput screening and bioinformatics analysis. Once a potential target is identified, the next step is to determine its specificity and safety.

RPS4XP11 is a potential drug target due to its involvement in cellular processes that are important for various cellular functions. In this article, we will explore the biology of RPS4XP11 and its potential as a drug target.

Biology of RPS4XP11

RPS4XP11 is a 21-kDa protein that is expressed in various tissues and cell types. It is primarily localized to the ER and cytosol, where it is involved in the regulation of protein stability and localization. RPS4XP11 is composed of a unique domain that includes a nucleotide-binding oligomerization (NBO) domain, a Rossmann-fold, and a carboxy-terminal domain.

The NBO domain is a structural feature that is commonly found in proteins that are involved in protein-protein interactions. It consists of a nucleotide-binding oligomerization domain and a catalytic domain. The NBO domain functions as a scaffold to facilitate the formation of protein- protein interactions.

The Rossmann-fold is a structural motif that is commonly found in proteins that are involved in protein-protein interactions. It consists of a parallel beta-sheet and a beta-hinge. The Rossmann-fold functions as a binding site for other proteins.

The carboxy-terminal domain is a structural feature that is involved in the regulation of protein stability and localization. It consists of a conserved domain that is involved in the formation of a covalent complex with other proteins.

Function of RPS4XP11

RPS4XP11 is involved in the regulation of protein stability and localization in the ER and cytosol. It helps to ensure that properly stable and localized proteins are available for various cellular functions.

One of the functions of RPS4XP11 is to regulate the stability of proteins in the ER. The ER is a specialized organelle that is responsible for the folding and storage of proteins. Proper stability and localization of proteins in the ER are important for their function and stability . RPS4XP11 helps to ensure that properly stable and localized proteins are available for various cellular functions.

RPS4XP11 is also involved in the regulation of protein stability in the cytosol. The cytosol is the fluid inside the cytoplasm that contains the cell's cytoplasmic organelles. Proper stability and localization of proteins in the cytosol are important for their function and stability. RPS4XP11 helps to ensure that properly stable and localized proteins are available for various cellular functions.

Potential Therapeutic Applications

The potential therapeutic applications of RPS4XP11 are vast. As a drug target, RPS4XP11 can be targeted with small molecules or other compounds that interact with its unique domain. Alternatively, RPS4XP11 can be used as a biomarker to diagnose and

Protein Name: Ribosomal Protein S4X Pseudogene 11

The "RPS4XP11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPS4XP11 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets